ProtocolEngine.io

NMN (Nicotinamide Mononucleotide)

Also known as: NMN, beta-NMN

BBuilding Evidence1 studies referenced

Common dosage

250-500mg daily

Category

nootropic

Description

NAD+ precursor being studied for cellular energy production and longevity. Human evidence is early but promising.

Safety & interactions

Long-term human safety data is limited. Take in the morning — may interfere with sleep if taken late.
Check all interactions →

Protocols featuring NMN (Nicotinamide Mononucleotide)

Studies on NMN (Nicotinamide Mononucleotide) (1)

1.

Nicotinamide mononucleotide supplementation improves aerobic capacity in amateur runners

Liao B, et al. (2022) · J Int Soc Sports Nutr · n=48

ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.